ESSA Pharma Inc Sustainability Reports
ESSA Pharma Inc. is a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. The company's pipeline includes therapies that disrupt androgen receptor signaling pathways to target cancer growth.
Sector: Manufacturing
Country: Canada
Exchange: Nasdaq
FIGI: BBG0080GLFK7
5 reports from 2020 to 2024
Company Profile
ESSA Pharma Inc. is a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. The company's pipeline includes therapies that disrupt androgen receptor signaling pathways to target cancer growth.
Reports
5 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
